476 related articles for article (PubMed ID: 10806439)
1. Perlecan in the basement membrane of corneal epithelium serves as a site for P. aeruginosa binding.
Chen LD; Hazlett LD
Curr Eye Res; 2000 Apr; 20(4):260-7. PubMed ID: 10806439
[TBL] [Abstract][Full Text] [Related]
2. Human corneal epithelial extracellular matrix perlecan serves as a site for Pseudomonas aeruginosa binding.
Chen L; Hazlett LD
Curr Eye Res; 2001 Jan; 22(1):19-27. PubMed ID: 11402375
[TBL] [Abstract][Full Text] [Related]
3. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN
Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988
[TBL] [Abstract][Full Text] [Related]
4. Disruption of the basement membrane after corneal débridement.
Sta Iglesia DD; Stepp MA
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1045-53. PubMed ID: 10752940
[TBL] [Abstract][Full Text] [Related]
5. Heparan sulfate of perlecan is involved in glomerular filtration.
Morita H; Yoshimura A; Inui K; Ideura T; Watanabe H; Wang L; Soininen R; Tryggvason K
J Am Soc Nephrol; 2005 Jun; 16(6):1703-10. PubMed ID: 15872080
[TBL] [Abstract][Full Text] [Related]
6. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
Vischer P; Feitsma K; Schön P; Völker W
Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
[TBL] [Abstract][Full Text] [Related]
7. Characterization of proteoglycans synthesized by murine embryonal carcinoma cells (P19) reveals increased expression of perlecan (heparan sulfate proteoglycan) during neuronal differentiation.
Sekiguchi RT; Potter-Perigo S; Braun K; Miller J; Ngo C; Fukuchi K; Wight TN; Kimata K; Snow AD
J Neurosci Res; 1994 Aug; 38(6):670-86. PubMed ID: 7807583
[TBL] [Abstract][Full Text] [Related]
8. Glomerular basement membrane-derived perlecan inhibits mesangial cell adhesion to fibronectin.
Gauer S; Schulze-Lohoff E; Schleicher E; Sterzel RB
Eur J Cell Biol; 1996 Jul; 70(3):233-42. PubMed ID: 8832207
[TBL] [Abstract][Full Text] [Related]
9. Basement membrane synthesis by human corneal epithelial cells in vitro.
Ohji M; SundarRaj N; Hassell JR; Thoft RA
Invest Ophthalmol Vis Sci; 1994 Feb; 35(2):479-85. PubMed ID: 8112997
[TBL] [Abstract][Full Text] [Related]
10. Visualization of the large heparan sulfate proteoglycan from basement membrane.
Laurie GW; Inoue S; Bing JT; Hassell JR
Am J Anat; 1988 Mar; 181(3):320-6. PubMed ID: 2452565
[TBL] [Abstract][Full Text] [Related]
11. Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors.
Smith SM; West LA; Govindraj P; Zhang X; Ornitz DM; Hassell JR
Matrix Biol; 2007 Apr; 26(3):175-84. PubMed ID: 17169545
[TBL] [Abstract][Full Text] [Related]
12. Expression of the basement membrane heparan sulfate proteoglycan (perlecan) in human synovium and in cultured human synovial cells.
Dodge GR; Boesler EW; Jimenez SA
Lab Invest; 1995 Nov; 73(5):649-57. PubMed ID: 7474938
[TBL] [Abstract][Full Text] [Related]
13. Basement membrane proteoglycans are of epithelial origin in rodent skin.
Yamane Y; Yaoita H; Couchman JR
J Invest Dermatol; 1996 Mar; 106(3):531-7. PubMed ID: 8648189
[TBL] [Abstract][Full Text] [Related]
14. Perlecan inhibits smooth muscle cell adhesion to fibronectin: role of heparan sulfate.
Lundmark K; Tran PK; Kinsella MG; Clowes AW; Wight TN; Hedin U
J Cell Physiol; 2001 Jul; 188(1):67-74. PubMed ID: 11382923
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide outer core is a ligand for corneal cell binding and ingestion of Pseudomonas aeruginosa.
Zaidi TS; Fleiszig SM; Preston MJ; Goldberg JB; Pier GB
Invest Ophthalmol Vis Sci; 1996 May; 37(6):976-86. PubMed ID: 8631641
[TBL] [Abstract][Full Text] [Related]
16. Biosynthesis of stromal matrix proteoglycans and basement membrane components by human corneal fibroblasts.
Hassell JR; Schrecengost PK; Rada JA; SundarRaj N; Sossi G; Thoft RA
Invest Ophthalmol Vis Sci; 1992 Mar; 33(3):547-57. PubMed ID: 1544783
[TBL] [Abstract][Full Text] [Related]
17. Production and characterization of a monoclonal antibody against human glomerular heparan sulfate.
van den Born J; van den Heuvel LP; Bakker MA; Veerkamp JH; Assmann KJ; Berden JH
Lab Invest; 1991 Sep; 65(3):287-97. PubMed ID: 1890809
[TBL] [Abstract][Full Text] [Related]
18. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice.
Zhou Z; Wang J; Cao R; Morita H; Soininen R; Chan KM; Liu B; Cao Y; Tryggvason K
Cancer Res; 2004 Jul; 64(14):4699-702. PubMed ID: 15256433
[TBL] [Abstract][Full Text] [Related]
19. Perlecan, a basement membrane-type heparan sulfate proteoglycan, in the enamel organ: its intraepithelial localization in the stellate reticulum.
Ida-Yonemochi H; Ohshiro K; Swelam W; Metwaly H; Saku T
J Histochem Cytochem; 2005 Jun; 53(6):763-72. PubMed ID: 15928325
[TBL] [Abstract][Full Text] [Related]
20. Hormonal modification of epithelial differentiation and expression of cell surface heparan sulfate proteoglycan in the mouse vaginal epithelium. An immunohistochemical and electron microscopic study.
Hayashi K; Hayashi M; Boutin E; Cunha GR; Bernfield M; Trelstad RL
Lab Invest; 1988 Jan; 58(1):68-76. PubMed ID: 2961930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
